Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Panitumumab + Capecitabine/Oxaliplatin in mCRC
NCT01215539Phase 2Completed
- Sponsor
- HeCOG
- Start
- Sep 2010
- Primary completion
- Aug 2014
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of panitumumab in metastatic colorectal cancer (mCRC), sponsored by HeCOG. Started Sep 2010; status: completed.
02
Drugs
panitumumab
03
Conditions
metastatic colorectal cancer (mCRC)
Beyond the preview
Go deeper on NCT01215539.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01215539.